These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 8280800)
21. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene. Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912 [TBL] [Abstract][Full Text] [Related]
22. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes. Willard-Gallo KE; Furtado M; Burny A; Wolinsky SM Eur J Immunol; 2001 Apr; 31(4):969-79. PubMed ID: 11298321 [TBL] [Abstract][Full Text] [Related]
23. Tat and Rev: positive regulators of HIV gene expression. Rosen CA; Pavlakis GN AIDS; 1990 Jun; 4(6):499-509. PubMed ID: 2201316 [No Abstract] [Full Text] [Related]
24. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector. Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446 [TBL] [Abstract][Full Text] [Related]
25. Derivation of a biologically contained replication system for human immunodeficiency virus type 1. Chen H; Boyle TJ; Malim MH; Cullen BR; Lyerly HK Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7678-82. PubMed ID: 1502183 [TBL] [Abstract][Full Text] [Related]
26. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments. Duan L; Zhu M; Bagasra O; Pomerantz RJ Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381 [TBL] [Abstract][Full Text] [Related]
27. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication. Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513 [TBL] [Abstract][Full Text] [Related]
28. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes. Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells. Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713 [TBL] [Abstract][Full Text] [Related]
30. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642 [TBL] [Abstract][Full Text] [Related]
31. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. Benko DM; Schwartz S; Pavlakis GN; Felber BK J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172 [TBL] [Abstract][Full Text] [Related]
32. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497 [TBL] [Abstract][Full Text] [Related]
33. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function. Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector. Cara A; Rybak SM; Newton DL; Crowley R; Rottschafer SE; Reitz MS; Gusella GL Gene Ther; 1998 Jan; 5(1):65-75. PubMed ID: 9536266 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat. Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310 [TBL] [Abstract][Full Text] [Related]
37. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Chang LJ; Zhang C Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208 [TBL] [Abstract][Full Text] [Related]
38. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells. Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640 [TBL] [Abstract][Full Text] [Related]
39. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity. Calarota SA; Kjerrström A; Islam KB; Wahren B Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166 [TBL] [Abstract][Full Text] [Related]
40. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy. Junker U; Böhnlein E; Veres G Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]